Ashley Graham calls the rise of GLP-1 weight loss shots disheartening as she vows to continue advocating for plus-size women ...

U.S. President Donald Trump announced on Friday that the federal government is taking steps to expand access to GLP-1 ...

The majority of weight loss from GLP-1 medication is from fat loss, and not muscle loss, new evidence suggests.

Starting July 2026, Medicare will pilot the 'GLP-1 Bridge,' a temporary program allowing some retirees coverage for weight loss drugs like Wegovy and Zepbound. The initiative marks a shift from ...

“This drug isn't going to wipe out a whole statistic of women,” the supermodel and activist said of the popular weight-loss ...

The National Psoriasis Foundation has issued a detailed primer supporting GLP-1 receptor agonists as an adjunct therapy for psoriasis in patients with metabolic comorbidities. Evidence shows these ...

Ashley Graham is not happy with what the prevalence of GLP-1 drugs is doing to body positivity. The popular plus-size model is the cover star of Marie Claire’s latest Motherhood Issue, and she ...

Ashley Graham criticises GLP-1 drugs and Ozempic trend, calling it a 'smack in the face' to body positivity in Hollywood and fashion.

The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare.

A majority of GLP-1 lawsuits come from patients who allege that manufacturers have inadequately warned about severe side ...

Ashley Graham is strutting into a conversation about weight loss drugs. The supermodel—who has been a longtime body positive ...